Pfizer lifted its full-year profit forecast following a better-than-expected third quarter on growth in its biopharma business
Health-centric wearables maker Fitbit has teamed up with several healthcare companies to look into adding an ECG feature, similar to what Apple has on the Apple Watch, to its activity trackers.
Pfizer has issued a recall for two batches of the Relpax migraine pill.
American pharmaceutical major Pfizer would acquire Array Biopharma to expand its portfolio of cancer drugs.
Here's what's behind the most unlikely Cinderella story the biopharma space has seen in a long time.
Putting an end to drug rebates to insurers could kick-start the use of low-cost biosimilar medications.
Amazon just beat Alphabet and Samsung to the top of biggest R&D spenders list.
According to polls, Republican Sen. Cindy Hyde-Smith holds a solid lead on Democrat Mike Espy in the Mississippi Senate race.
A peek into the likely future for the big drugmaker.
Several major pharmaceutical companies this week have made announcements about the prices of their prescription drugs but does it mean customers will see a decrease in prices?
The investment by pharmaceutical company Pfizer, widely known as the maker of Viagra, will also create over 450 jobs in Michigan, the company said in a statement Tuesday.
Blockchain systems could keep years of patient data secure and make any human errors in data entry easy to track down and correct.
Donald Trump called Pfizer Chief Executive Ian Read on Tuesday to say the company’s July 1 price hikes had complicated the administration’s drug pricing plans, prompting the company to defer its planned increases, according to a source familiar with the matter.
Pfizer CEO Ian Read received a 61 percent raise in 2017 while the company raised the cost of its drugs.
The new pill would be available for $32.50, half that of the existing $65 per-pill price.
Congressional staffers, lobbyists and think tank employees will get together for an annual D.C. tradition imbued with extra significance this year: the Tax Foundation’s gala, brought to you by 61 corporations interested in seeing their tax bills reduced.
New York’s $192 billion pension fund put forward a shareholder resolution that would’ve forced Cardinal Health to demonstrate that its products weren’t being used in lethal injections. Regulators stood in the way.
Zykadia more than doubled the median progression-free survival rate for patients suffering from anaplastic lymphoma kinase-positive nonsmall cell lung cancer.
The U.S. drugmaker’s move comes soon after GlaxoSmithKline announced a similar decision in September.
The all-cash deal for Medivation, which markets a blockbuster prostate cancer drug, is not expected to affect Pfizer’s 2016 financial guidance.
Buffett's Berkshire Hathaway disclosed a stake in the iPhone maker worth about $1 billion.
The deal would give the American pharmaceutical giant access to Anacor's flagship eczema treatment gel Crisaborole.